Deutsche Bank’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-293,254
Closed -$29.4M 5644
2015
Q1
$29.4M Buy
293,254
+273,799
+1,407% +$18.2M 0.02% 754
2014
Q4
$1.02M Buy
19,455
+8,907
+84% +$262K ﹤0.01% 3198
2014
Q3
$270K Buy
10,548
+9,203
+684% +$196K ﹤0.01% 3901
2014
Q2
$29K Sell
1,345
-1,295
-49% -$28.3K ﹤0.01% 5183
2014
Q1
$81K Buy
+2,640
New +$70.9K ﹤0.01% 4323

Deutsche Bank's ASPX Position: Q2 2015 in Review

Deutsche Bank sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 293,254 shares — an estimated $29.4M sold.

Deutsche Bank first reported a position in ASPX in Q1 2014 and held it in 5 quarters. The position peaked at $29.4M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • Deutsche Bank reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Deutsche Bank sold 293,254 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $29.4M.
  • Deutsche Bank first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 5 quarters.
  • Deutsche Bank's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $29.4M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Deutsche Bank's 13F filing for Q2 2015, filed 12 Aug 2015.